Enhanced radio-sensitivity of PTEN-deficient prostate tumours mediated by inhibition of intrinsic and treatment-potentiated CXC-chemokine signaling

Chris Armstrong, Jonathan Coulter, Chee Wee Ong, Pamela Maxwell, Melissa LaBonte Wilson, Karl Butterworth, Oksana Lyubomska, Silvia Berlingeri, R. Gallagher, Steven Walker, Joseph O'Sullivan, Ian Mills, Manuel Salto-Tellez, T Illidge, R.G. Bristow, Richard Kennedy, Kevin Prise, David Waugh

Research output: Contribution to conferencePoster

Original languageEnglish
Publication statusPublished - 2017
EventEuropean Alliance for Personalised Medicine Conference : “Personalising your Health: A Global Imperative” - Belfast, United Kingdom
Duration: 25 Nov 201729 Nov 2017

Conference

ConferenceEuropean Alliance for Personalised Medicine Conference
CountryUnited Kingdom
CityBelfast
Period25/11/201729/11/2017

Cite this

Armstrong, C., Coulter, J., Ong, C. W., Maxwell, P., LaBonte Wilson, M., Butterworth, K., Lyubomska, O., Berlingeri, S., Gallagher, R., Walker, S., O'Sullivan, J., Mills, I., Salto-Tellez, M., Illidge, T., Bristow, R. G., Kennedy, R., Prise, K., & Waugh, D. (2017). Enhanced radio-sensitivity of PTEN-deficient prostate tumours mediated by inhibition of intrinsic and treatment-potentiated CXC-chemokine signaling. Poster session presented at European Alliance for Personalised Medicine Conference , Belfast, United Kingdom.